Menu

Blog

Archive for the ‘biotech/medical’ category: Page 400

Sep 21, 2023

Tiny implanted devices give insights for treating brain tumors

Posted by in categories: biotech/medical, neuroscience

A tiny device implanted during brain surgery could help provide personalized information about a tumor’s potential responses to cancer-fighting drugs.

Sep 21, 2023

Scientists Discover That the Genes for Learning and Memory Are 650 Million Years Old

Posted by in categories: biotech/medical, chemistry, genetics

A team of scientists led by researchers from the University of Leicester has determined that genes responsible for learning, memory, aggression, and other complex behaviors emerged approximately 650 million years ago.

The research spearheaded by Dr. Roberto Feuda, of the Neurogenetic group within the Department of Genetics and Genome Biology, in collaboration with colleagues from the University of Leicester and the University of Fribourg (Switzerland), has recently been published in the journal Nature Communications.

<em>Nature Communications</em> is a peer-reviewed, open-access, multidisciplinary, scientific journal published by Nature Portfolio. It covers the natural sciences, including physics, biology, chemistry, medicine, and earth sciences. It began publishing in 2010 and has editorial offices in London, Berlin, New York City, and Shanghai.

Sep 21, 2023

Natural Killer Cells Could be the Key to New Treatment Options for Blood Cancers

Posted by in category: biotech/medical

Natural killer (NK) cells represent an important class of immune cells involved in anti-tumor immunity. Once identifying a tumor cell, NK cells use small particles to kill the cancer cell.

Our understanding of the role of NK cells in anti-tumor immunity has led to the development of techniques that transfer NK cells from a healthy individual into a cancer patient. Such approaches, known as allogeneic NK cell adoptive transfer, have effectively treated certain types of leukemia and lymphoma. While such strategies can induce remission, clinical challenges about the survival and function of the transferred NK cells exist. Thus, research focused on enhancing the ability of transferred NK cells to survive and maintain their ability to function has become highly valuable in an effort to provide new, efficacious therapeutic options.

A new report published in Science Translational Medicine finds that a vitamin supplement could effectively improve the efficacy of NK cell adoptive transfer treatment. Supported by pre-clinical studies, the investigators conducted a phase 1 clinical trial to test a new method for processing NK cells before transferring them to a patient.

Sep 21, 2023

Mesoporous Nano-Badminton with Asymmetric Mass Distribution: How Nanoscale Architecture Affects the Blood Flow Dynamics

Posted by in categories: biotech/medical, nanotechnology

While the nanobio interaction is crucial in determining nanoparticles’ in vivo fate, a previous work on investigating nanoparticles’ interaction with biological barriers is mainly carried out in a static state. Nanoparticles’ fluid dynamics that share non-negligible impacts on their frequency of encountering biological hosts, however, is seldom given attention. Herein, inspired by badmintons’ unique aerodynamics, badminton architecture Fe3O4&mPDA (Fe3O4 = magnetite nanoparticle and mPDA = mesoporous polydopamine) Janus nanoparticles have successfully been synthesized based on a steric-induced anisotropic assembly strategy. Due to the “head” Fe3O4 having much larger density than the mPDA “cone”, it shows an asymmetric mass distribution, analogous to real badminton.

Sep 21, 2023

Eric Drexler | MSEP: What, Why, and How?

Posted by in categories: biotech/medical, computing, nanotechnology

Foresight Molecular Machines Group.
Program & apply to join: https://foresight.org/molecular-machines/

This video was recorded at the 2022 Foresight Designing Molecular Machines Workshop. https://foresight.org/molecular-workshop/

Continue reading “Eric Drexler | MSEP: What, Why, and How?” »

Sep 21, 2023

Retinal Imaging And Machine Learning Honored In The 2023 Lasker Awards

Posted by in categories: biotech/medical, health, robotics/AI

Many ophthalmologists’ offices around the country are home to a machine that enables doctors to take advantage of optical coherence tomography (OCT), a method of imaging the retina and other tissues in the eye. These OCT machines give doctors insight into the three-dimensional structures of their patients’ eyes, help them diagnose diseases and can even help save their patients’ sight.

The genesis of OCT machines began in the lab of Dr. James Fujimoto, who was inspired by advances in high-speed photography and lasers to start developing potential methods that would enable doctors to get better images of what was happening inside of people’s bodies. The goal, he told Forbes, was to develop… More.


In 1991, the trio published their first paper describing the technique they invented. “In less than a year, we were able to develop this new imaging technology, which in retrospect was pretty unusual,” Huang told Forbes.

Continue reading “Retinal Imaging And Machine Learning Honored In The 2023 Lasker Awards” »

Sep 21, 2023

Google DeepMind’s new AI tool can predict genetic diseases

Posted by in categories: biotech/medical, genetics, robotics/AI

DeepMind has released a catalog of 71 million possible variants that can cause diseases.

Genetic mutations are changes to our DNA sequence. This happens when cells make copies of themselves during cell division. Mutation is the ultimate source of human genetic variation and has evolutionary and disease genetics implications. A mutation affecting our genes might give birth to a genetic disorder. But just because you have a mutation doesn’t mean it will be a genetic disorder.

That is why researchers at DeepMind, the artificial intelligence arm of Google, have announced that they have trained a machine learning model called AlphaMissense to classify which DNA variations in our genomes are likely to cause disease.

Sep 21, 2023

Neuralink to recruit people with paralysis for first human trials

Posted by in categories: biotech/medical, Elon Musk, robotics/AI

Past tests have been conducted on pigs.

On Tuesday, Elon Musk’s Neuralink announced it was ready to start its first human trials. “We are happy to announce that we’ve received approval from the reviewing independent institutional review board and our first hospital site to begin recruitment for our first-in-human clinical trial,” noted a blog on the company’s website.

The PRIME Study (short for Precise Robotically Implanted Brain-Computer Interface) – a groundbreaking investigational medical device trial for our fully-implantable, wireless brain-computer interface (BCI) – aims to evaluate the safety of our implant (N1) and surgical robot (R1) and assess the initial functionality of our BCI for… More.

Continue reading “Neuralink to recruit people with paralysis for first human trials” »

Sep 21, 2023

Exploring the mind-mitochondria connection

Posted by in categories: biotech/medical, health, neuroscience

As befits the child of a scientist, Martin Picard’s young son, 3, is already learning about biology with an age-appropriate textbook, “Cell Biology for Babies.” Picard winces a little whenever the book calls mitochondria the “powerhouses of the cell” but figures he has plenty of time as his son grows older to explain why the tiny organelles are much more than simple energy sources.

Picard is a leading proponent of mitochondrial psychobiology (a phrase he coined), an emerging field that examines how psychological states like stress influence mitochondrial functions, which in turn influence mental and physical health.

Continue reading “Exploring the mind-mitochondria connection” »

Sep 21, 2023

Google DeepMind AI speeds up search for disease genes

Posted by in categories: biotech/medical, robotics/AI

Google DeepMind has used its technology to identify parts of human DNA that might cause diseases.

Page 400 of 2,685First397398399400401402403404Last